What is Tarsus Pharmaceuticals, Inc.'s raw materials?

Tarsus Pharmaceuticals, Inc. (TARS) reported raw materials of $2.53M in Q1 2026.

How has Tarsus Pharmaceuticals, Inc.'s raw materials changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s raw materials decreased by 0.2% year-over-year, from $2.53M to $2.53M.

What does raw materials mean?

The net value of raw materials held in inventory that are not expected to be consumed or converted into finished goods within the standard operating cycle. This represents long-term supply commitments or strategic stockpiles held by the company.

Tarsus Pharmaceuticals, Inc. TARS Raw materials

Raw materials at other companies

Mondelez InternationalMDLZ

$981M-15.4%

International Flavors & FragrancesIFF

$737M-3.0%

Raytheon TechnologiesRTX

$4.98B+10.8%

Exxon MobilXOM

$3.14B-21.1%

Altria GroupMO

$265M+35.9%

nVent Electric plcNVT

$250.1M+62.5%

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept tars:InventoryRawMaterialsNoncurrentNetOfReserves.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s raw materials?: Tarsus Pharmaceuticals, Inc. (TARS) reported raw materials of $2.53M in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s raw materials changed year-over-year?: Tarsus Pharmaceuticals, Inc.'s raw materials decreased by 0.2% year-over-year, from $2.53M to $2.53M.
What does raw materials mean?: The net value of raw materials held in inventory that are not expected to be consumed or converted into finished goods within the standard operating cycle. This represents long-term supply commitments or strategic stockpiles held by the company.